These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 28290974

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Antiretroviral Therapy, Especially Efavirenz, Is Associated with Low Bone Mineral Density in HIV-Infected South Africans.
    Dave JA, Cohen K, Micklesfield LK, Maartens G, Levitt NS.
    PLoS One; 2015; 10(12):e0144286. PubMed ID: 26633015
    [Abstract] [Full Text] [Related]

  • 4. Impaired sperm motility in HIV-infected men: an unexpected adverse effect of efavirenz?
    Frapsauce C, Grabar S, Leruez-Ville M, Launay O, Sogni P, Gayet V, Viard JP, De Almeida M, Jouannet P, Dulioust E.
    Hum Reprod; 2015 Aug; 30(8):1797-806. PubMed ID: 26085581
    [Abstract] [Full Text] [Related]

  • 5. Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS Syndrome).
    Holbrook MB, Glick J.
    J Emerg Med; 2019 May; 56(5):562-563. PubMed ID: 30879852
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Rilpivirine versus efavirenz with two background nucleoside or nucleotide reverse transcriptase inhibitors in treatment-naive adults infected with HIV-1 (THRIVE): a phase 3, randomised, non-inferiority trial.
    Cohen CJ, Andrade-Villanueva J, Clotet B, Fourie J, Johnson MA, Ruxrungtham K, Wu H, Zorrilla C, Crauwels H, Rimsky LT, Vanveggel S, Boven K, THRIVE study group.
    Lancet; 2011 Jul 16; 378(9787):229-37. PubMed ID: 21763935
    [Abstract] [Full Text] [Related]

  • 8. Efavirenz Pharmacokinetics and Pharmacodynamics in HIV-Infected Persons Receiving Rifapentine and Isoniazid for Tuberculosis Prevention.
    Podany AT, Bao Y, Swindells S, Chaisson RE, Andersen JW, Mwelase T, Supparatpinyo K, Mohapi L, Gupta A, Benson CA, Kim P, Fletcher CV, AIDS Clinical Trials Group A5279 Study Team.
    Clin Infect Dis; 2015 Oct 15; 61(8):1322-7. PubMed ID: 26082504
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Factors associated with seminal impairment in HIV-infected men under antiretroviral therapy.
    Jerónimo A, Baza MB, Río I, Vera M, Hernando V, Castilla J, Rodriguez C, Del Romero J.
    Hum Reprod; 2017 Feb 15; 32(2):265-271. PubMed ID: 28007791
    [Abstract] [Full Text] [Related]

  • 11. [Tenofovir hypersensitivity to tenofovir (DRESS) syndrome in a female patient infected by HIV].
    Bayonne Kombo ES, Gathse A.
    Med Mal Infect; 2013 Mar 15; 43(3):134-5. PubMed ID: 23434355
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Combination therapy with efavirenz, nelfinavir, and nucleoside reverse-transcriptase inhibitors in children infected with human immunodeficiency virus type 1. Pediatric AIDS Clinical Trials Group 382 Team.
    Starr SE, Fletcher CV, Spector SA, Yong FH, Fenton T, Brundage RC, Manion D, Ruiz N, Gersten M, Becker M, McNamara J, Mofenson LM, Purdue L, Siminski S, Graham B, Kornhauser DM, Fiske W, Vincent C, Lischner HW, Dankner WM, Flynn PM.
    N Engl J Med; 1999 Dec 16; 341(25):1874-81. PubMed ID: 10601506
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Hypersensitivity to efavirenz treated with corticosteroids in a 6-year-old child.
    Foti JL, Piatt JP.
    AIDS Patient Care STDS; 2003 Jan 16; 17(1):1-3. PubMed ID: 12614514
    [Abstract] [Full Text] [Related]

  • 18. A randomized trial comparing plasma drug concentrations and efficacies between 2 nonnucleoside reverse-transcriptase inhibitor-based regimens in HIV-infected patients receiving rifampicin: the N2R Study.
    Manosuthi W, Sungkanuparph S, Tantanathip P, Lueangniyomkul A, Mankatitham W, Prasithsirskul W, Burapatarawong S, Thongyen S, Likanonsakul S, Thawornwa U, Prommool V, Ruxrungtham K, N2R Study Team.
    Clin Infect Dis; 2009 Jun 15; 48(12):1752-9. PubMed ID: 19438397
    [Abstract] [Full Text] [Related]

  • 19. A 28-year-old woman with fever, rash, and pancytopenia.
    Ochoa S, Cheng K, Fleury CM, Luccioli S, Bellanti JA.
    Allergy Asthma Proc; 2017 Jul 01; 38(4):322-327. PubMed ID: 28668113
    [Abstract] [Full Text] [Related]

  • 20. Evidence for a shift to anaerobic metabolism in adipose tissue in efavirenz-containing regimens for HIV with different nucleoside backbones.
    McGee KC, Shahmanesh M, Boothby M, Nightingale P, Gathercole LL, Tripathi G, Harte AL, Shojaee-Moradie F, Umpleby AM, Das S, Al-Daghri NM, McTernan PG, Tomlinson JW.
    Antivir Ther; 2012 Jul 01; 17(3):495-507. PubMed ID: 22300946
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.